Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,502.80
(
0.15%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
109.09
(
-2.93%
)
Bitcoin
76,070.75
(
0.39%
)
News Focus
News Focus
Post# of 517654
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

georgesk

Send PM Follow Ignore
Followers 7
Posts 315
Boards Moderated 0
Alias Born 03/31/2016

georgesk

Re: Investor2014 post# 140842

Tuesday, 02/13/2018 8:52:36 AM

Tuesday, February 13, 2018 8:52:36 AM

Post# of 517654

The quest to promote the idea that A2-73 is not tolerable forcing low dose in the P2a Part B trial and beyond has no basis in fact.



I'm not making that claim, far from it. Not my expertise.

Just curious what the dosage will be for Rett trial. It has to be lower, the target population is children with smaller body mass.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News